| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF LEGAL OFFICER | Restricted Stock Units | 20.1K | $1.02M | $50.62 | Jun 12, 2024 | Direct |
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF LEGAL OFFICER | Common Stock | 11.7K | $422K | $36.10 | Feb 16, 2024 | Direct |
| HALOZYME THERAPEUTICS, INC. | SVP, CHIEF LEGAL OFFICER | Option to Purchase Common Stock | 29.1K | $403K | $13.87 | Feb 23, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | SVP, CHIEF LEGAL OFFICER |
| HALO | HALOZYME THERAPEUTICS, INC. | Feb 23, 2024 | 2 | $0 | 4 | Feb 27, 2024 | SVP, GENERAL COUNSEL |
| HALO | HALOZYME THERAPEUTICS, INC. | Feb 16, 2024 | 3 | -$93K | 4 | Feb 20, 2024 | SVP, GENERAL COUNSEL |
| HALO | HALOZYME THERAPEUTICS, INC. | Jan 3, 2024 | 3 | -$106K | 4 | Jan 5, 2024 | SVP, GENERAL COUNSEL |
| HALO | HALOZYME THERAPEUTICS, INC. | Feb 16, 2023 | 2 | $0 | 4 | Feb 21, 2023 | SVP, GENERAL COUNSEL |
| HALO | HALOZYME THERAPEUTICS, INC. | Jan 3, 2023 | 3 | -$155K | 4 | Jan 4, 2023 | SVP, GENERAL COUNSEL |
| HALO | HALOZYME THERAPEUTICS, INC. | Jan 3, 2022 | 2 | $0 | 4 | Jan 5, 2022 | SVP, General Counsel |
| HALO | HALOZYME THERAPEUTICS, INC. | Jan 3, 2022 | 0 | $0 | 3 | Jan 5, 2022 | SVP, General Counsel |